-- Shandong Xinhua Pharmaceutical (HKG:0719, SHE:000756) recorded a 25% decline in attributable profit in the first quarter of 2026 to 83.9 million yuan from 112.1 million yuan a year prior, according to a Tuesday Hong Kong bourse filing.
Earnings per share slipped to 0.12 yuan from 0.15 yuan in the corresponding period of the previous fiscal year.
The pharma firm's operating income slipped 0.3% to 2.42 billion yuan from 2.43 billion yuan in the year-ago period.